The β 1 -adrenergic receptor (β 1 AR) is a G-protein-coupled receptor whose inactive state structure was determined using a thermostabilized mutant (β 1 AR-M23). However, it was not thought to be in a fully inactivated state because there was no salt bridge between Arg139 and Glu285 linking the cytoplasmic ends of transmembrane helices 3 and 6 (the R 3.50 − D∕E 6.30 "ionic lock"). Here we compare eight new structures of β 1 AR-M23, determined from crystallographically independent molecules in four different crystals with three different antagonists bound. These structures are all in the inactive R state and show clear electron density for cytoplasmic loop 3 linking transmembrane helices 5 and 6 that had not been seen previously. Despite significantly different crystal packing interactions, there are only two distinct conformations of the cytoplasmic end of helix 6, bent and straight. In the bent conformation, the Arg139-Glu285 salt bridge is present, as in the crystal structure of darkstate rhodopsin. The straight conformation, observed in previously solved structures of β-receptors, results in the ends of helices 3 and 6 being too far apart for the ionic lock to form. In the bent conformation, the R 3.50 − E 6.30 distance is significantly longer than in rhodopsin, suggesting that the interaction is also weaker, which could explain the high basal activity in β 1 AR compared to rhodopsin. Many mutations that increase the constitutive activity of G-protein-coupled receptors are found in the bent region at the cytoplasmic end of helix 6, supporting the idea that this region plays an important role in receptor activation.
membrane protein | seven-transmembrane receptor | conformational thermostabilization T he G-protein-coupled receptor (GPCR) superfamily is responsible for the transduction of a wide variety of extracellular signals, and they are found in almost all eukaryotes, with over 800 different GPCRs in humans (1, 2) . Their common seventransmembrane-domain architecture has been preserved and evolved to sense agonists with remarkable structural diversity and to couple to a variety of specific signaling pathways. The structures of rhodopsin (3-7), the β 1 -and β 2 -adrenergic receptors (β 1 AR and β 2 AR) (8) (9) (10) (11) . the adenosine A 2A receptor (A 2A R) (12), the dopamine D3 receptor (13) , and the CXCR4 chemokine receptor (14) show that there is a similar overall architecture for all family A GPCRs (reviewed in refs. [15] [16] [17] , and there is probably a corresponding underlying conservation of the activation process (18, 19) . With this wealth of structural information, the challenge is now to correlate the pharmacological properties of the hormone-binding receptors with their structure. One functional aspect that still requires a structural explanation is the phenomenon of basal activity-i.e., most GPCRs show some ability to activate G proteins even in the absence of agonists (20, 21) -and this will be the focus of this report.
Our current understanding of the structural basis for receptor activation is based largely on the structures determined for the dark-state of rhodopsin (R state) (3) (4) (5) and its light-activated conformation, opsin (R* state) (6, 7). Rhodopsin and its close homologues are unique amongst GPCRs because they contain a covalently bound inverse agonist, 11-cis retinal, which is converted by a photon of light to all-trans retinal, which is a full agonist for the receptor. Thus rhodopsin functions as a binary switch, the photon of light converting an inactive form of receptor to one that is fully competent to activate G proteins (reviewed in ref. 22) .
It is essential that rhodopsin shows no G-protein-coupling activity in the absence of light and, therefore, it has evolved to have absolutely no basal activity within the lifetime of rhodopsin in the cell. Consequently, it is accepted that the structure of dark-state rhodopsin represents the fully inactive state of a GPCR. Upon activation by light, numerous conformational changes around the retinal binding pocket result in the cytoplasmic end of transmembrane helix 6 (H6) straightening and moving 6 Å away from the center of the molecule, accompanied by a smaller movement and rotation of transmembrane helix 5 (H5). The movements of H5 and H6 create a cleft in the cytoplasmic face of the opsin that allows the binding of the C-terminal helix of Gα, thus activating the G protein.
A key feature of rhodopsin activation is the outward movement of H6 away from H3 (6, 7, 23) . In the rhodopsin structure, there is a salt-bridge R 3.50 − E 6.30 (Ballesteros-Weinstein numbering system is in superscripts; ref. 24) , which links the cytoplasmic ends of H6 and H3. Both R 3.50 and D∕E 6.30 are highly conserved throughout the GPCR superfamily and, prior to the structure determination of rhodopsin, had already been suggested to provide a constraint that stabilized the inactive state of GPCRs, leading to this interaction being termed the ionic lock (25) . In the case of rhodopsin, the R 3.50 − E 6.30 salt bridge was proposed to be one of the major determinants for the stability of the inactive state.
Hormone receptors have a far more complex pharmacology than does rhodopsin. Many hormone-binding GPCRs can partially activate their respective G proteins in the absence of agonist ligand (26) . The extent of this activity varies among GPCRs and their subtypes, reflecting different needs for a basal level of signaling in a physiological context. Receptors with no basal activity, such as rhodopsin, seem appropriate for mediating sensory inputs that control how well we can see in the dark, where any basal activity would add undesirable noise. In contrast, increased levels of basal activity may be more useful for the controlled modulation of an activity such as heart rate that varies over a range of only two-to fivefold. It is thought that basal activity is caused by a subset of receptor conformations, which resemble the fully activated agonist-bound state despite the absence of bound agonist, and that these can bind and activate their respective G proteins.
Recent structures of β 1 AR and β 2 AR have greatly increased our understanding of how ligands are recognized and the overall architecture of the receptors (8) (9) (10) (11) 27) . However, there are also many questions that remain unresolved. One feature of all of the β-receptor structures is that they appear to represent inactive states (i.e., they are most similar to the structure of dark-state rhodopsin), yet the ionic lock between helices 3 and 6 is invariably broken. This observation raises the question of whether the β-receptors can adopt a conformation analogous to dark-state rhodopsin and, if so, how this affects their basal activity. Existing β-receptor crystal structures cannot address this issue, because either the cytoplasmic end of H6 is disordered and unresolved or it is potentially perturbed by the interaction with an antibody fragment or a T4 lysozyme fusion. Here we present eight structures of the β 1 AR, which show that the receptor can indeed form an inactive state with an ionic lock analogous to the dark-state of rhodopsin, in addition to an inactive state where the ionic lock is broken.
Results
Crystallization and Structure Determination. The turkey β 1 AR construct that was crystallized contains amino acid deletions in the flexible regions at the N and C termini and in cytoplasmic loop 3 (CL3), and is called β36 (28) . Six thermostabilizing mutations were introduced to make the receptor more tolerant to shortchain detergents (29) , resulting in the β36-m23 construct whose structure was determined to 2.7-Å resolution with cyanopindolol bound (11) . During the extensive screening required to obtain these crystals (29) , lower resolution datasets were collected from a variety of crystals containing either bound cyanopindolol (crystals t148, t468, resolution limits 3.25 and 3.15 Å) or iodocyanopindolol (crystal t756, resolution limit 3.65 Å). Cocrystallization of β36-m23 with the high-affinity antagonist carazolol also led to crystals suitable for structure determination (crystal t1118, resolution limit 3.00 Å). All structures were solved by molecular replacement using the structure of β36-m23 (PDB ID code 2VT4) as a model. There are two monomers (A and B) in the crystallographic asymmetric unit of each crystal, resulting in a total of eight structures for β36-m23. Data collection and refinement statistics are shown in Table S1 .
are not the result of different crystal growth conditions. In addition, the two conformations show no correlation to the nature of antagonist ligand. The importance of the CL3 region in forming lattice contacts probably explains the success of the deletions made to enhance crystallization (residues 244-271 and 277-278). The full length CL3 is likely to be conformationally mobile, hindering formation of a stable crystal lattice.
Overall Comparison of the β 1 AR Structures
The eight receptor structures, regardless of the type of antagonist bound, are very similar to the previously reported cyanopindololbound structure with respect to the hydrophobic transmembrane regions (residues 54-67, 78-101, 114-143, 158-179, 208-234, 289-306, 323-345) with rmsds for C α atoms ranging from 0.03 to 0.53 Å (Table S3 ). There are also only minor differences in the previously defined extracellular and intracellular loops (rmsds in C α atoms 0.6-0.7 Å). However, in the case of CL3, there were substantial differences between some of the monomers. CL3 comprises the cytoplasmic extensions to transmembrane helices H5 and H6 and a relatively short loop in an extended conforma- tion between them. In the previous structure of β 1 AR (PDB ID code 2VT4), 15 residues in the CL3 region (239-283, but note that residues 244-271 and 277-278 are not in the construct) were disordered and therefore not modeled (11) . Amongst the eight structures reported here, two distinct conformations of the CL3 region were observed (Fig. 2) . Both conformations are clearly in the inactive R state as neither show the characteristic conformation changes observed in opsin.
Structural Differences in CL3 and H6
Transmembrane helix H6 in the published structure of cyanopindolol-bound β 1 AR-M23 (11) extends from residue Glu285 6.30 to Phe315 6.60 , with a single kink formed by Pro305 6.50 . The cytoplasmic membrane boundary is estimated to be in the region of Ala288 to Leu289, so the cytoplasmic helical extension of H6 is relatively short (5-6 residues). In one of the two distinct conformations of CL3 observed in the new structures, the conformation of H6 is unchanged but the cytoplasmic extension is longer by approximately 10 Å, starting at residue Lys276. In the second conformation, there is a marked kink in the cytoplasmic extension of H6 at residue Ala288 6.33 (t1118, t148) or Lys287 6.32 (t756). Residues 274-286 are still α-helical and the helix is just as long, but the helix axis is bent by about 35°toward CL2 and rotated about 10°around the helix axis clockwise if viewed from the cytoplasmic side. The two conformations are therefore referred to as "straight" or "bent" accordingly (Fig. 3) . The folding of the CL3 region is highly conserved within these two conformations (rmsds in C α atoms of 0.28-0.39 Å for four structures in the straight conformation and 0.97-1.21 Å for four structures in the bent conformation; Fig. 2 , Tables S3 and S4 ).
In structures with H6 in the bent conformation, H5 is extended by one helical turn relative to H6 in the straight conformation. The remaining residues Lys240-Ser273 (bent conformation), Gln237-Arg275 (straight conformation) form an extended loop. The omit densities for the CL3 region in the carazolol structure are shown in Fig. 2 . The electron density for the bent conformation is systematically better defined in all structures. The straight conformation has breaks in the density that correspond to the residues with very high B factors in this region.
The bent conformation of H6 is partially stabilized by van der Waals interactions primarily involving Met281 and Leu282 with side chains on H5. The salt bridge between the highly conserved Arg139 3.50 of the E(D)RY motif on H3 and Glu285 6.30 on H6 (the ionic lock) will provide additional stabilization. However, the minimum distance between a nitrogen atom of the guanidinium group of Arg139
3.50 and a carboxylate oxygen of Glu285
6.30 (the N-O distance) is consistently between 3.7-3.9 Å in the bent conformation, which is significantly longer than seen in dark-state rhodopsin (2.8-3.2 Å; Table S4 ). An additional potential hydrogen bond is formed between His286 and Gln237 in H5. All these polar interactions are absent in the straight conformation of H6, with a minimum N-O distance for the ionic lock of 6.2 Å. In the straight conformation of H6, there are no hydrogen bonds apparent between the cytoplasmic extension of H6 and the neighboring H5, although there are van der Waals contacts between Leu282 in H6 and Ile241 in H5.
Discussion
Crystallization of β 1 AR-M23 in different crystal forms with three different ligands has resulted in receptor structures that are virtually identical except for the different conformations of the cytoplasmic end of H6. The fact that only two conformations of H6 are observed, either bent or straight, despite the range of different crystallization conditions and crystal packing interactions, suggests that these reflect unbiased conformations that could be adopted in the native cell membranes. This idea is consistent with current thinking that GPCRs are in a finely balanced dynamic equilibrium between multiple inactive states and multiple activated states, even in the absence of ligands (18, 19) . Recent molecular dynamics simulations performed on the β 2 AR also indicate the coexistence of two different inactive conformations with the ionic lock either intact or disrupted (30) . The conformation corresponding to an intact ionic lock in the β 2 AR simulation is broadly similar to that observed in the crystal structures, except that H6 was described as kinking slightly at Gly276 6.38 compared with the more marked kink observed at Lys287 6.32 ∕Ala288 6.33 in β 1 AR. Given that the bent conformation is very similar to that observed in rhodopsin (Figs. S2 and S3), this structure probably represents the most inactive state of receptor -i.e., the conformation that would be expected if an inverse agonist were bound (R inv ). In this conformation, the cytoplasmic extension of H6 blocks the G-protein peptide binding site observed in the low-pH structure of opsin (7). In the straight conformation, there is still insufficient room for the C-terminal peptide of the G protein to insert into the receptor, so further conformational changes upon agonist binding are required for productive G-protein coupling. Thus transformation of H6 by the conformational dynamics of the H286 6.31 KAL289 6.34 region is one of the essential steps required for G-protein signaling. Rhodopsin is unusual amongst GPCRs because its basal activity is virtually zero, which has been ascribed in part to the ionic lock between R 3.50 and E 6.30 with the distance between the N-O of the side chains being 2.8-3.2 Å. In contrast, the basal activity of
The difference in the length of the ionic interaction will undoubtedly affect its strength and hence the conformational flexibility of the region, which could contribute to the higher basal activity of β 1 AR. However, clearly this is not the only structural feature in GPCRs that affects basal activity. For example, the naturally occurring polymorphism in human β 2 AR, T164I 4.56 , is at the H4-H5 interface and significantly reduces both basal activity and the agonist-induced activation of the receptor (31) . In addition, the recent structure of the dopamine (D3) receptor (D3R) shows that it contains an intact ionic lock, with the N-O distance of 2.5 Å (13). There is also no perceptible kink in the cytoplasmic end of H6 of D3R equivalent to the kink observed in the β 1 AR structures presented here. Thus, although the region of the ionic lock is conserved, there are clearly subtle variations in the structure between different receptors.
The ability of the HKAL sequence to have two structurally different conformations constitutes a ligand-independent mechanism that could affect the basal activity of β 1 AR and other GPCRs, depending upon where the equilibrium between the different conformations of the cytoplasmic extension of H6 lies. If the equilibrium in one GPCR favors the bent conformation with an intact ionic lock (R inv ), as is found in rhodopsin, then the basal activity of the receptor is likely to be low; a strong salt bridge between R 3.50 −D∕E 6.30 will produce this situation. If the salt bridge is weak or absent, the equilibrium will favor formation of the straight conformation where the ionic lock is open. Once this state is attained, there are no strong interactions between the cytoplasmic ends of H3 and H6 that will hinder the movement of H6 to adopt the conformation (R*) capable of coupling to G proteins; i.e., the probability of R* formation increases once the ionic lock is open. Thus the dynamics of the HKAL region can potentially have an effect on the level of basal activity of a receptor and in this regard it is noteworthy that many constitutively activating mutations are found here, particularly in position 6.34 (Fig. 4) . Thus the HKAL region has probably evolved to maintain a level of basal activity that is compatible with the physiological function of the receptor, with some receptors having higher levels of basal activity than others. However, there are many sites that can affect the basal activity of receptors, and the importance of the HKAL sequence might not be general for all rhodopsin-like GPCRs. For example, the M5 muscarinic receptor, when mutated in the same 6.34 site, was devoid of constitutive activity although this site was still found to be the determinant of M5 receptor affinity to the G protein (32) . In contrast, all 19 amino acids substitutions in this site in the α1B adrenergic Fig. 4 . Sites of constitutively activating mutations (CAMs) in the CL3 region for different GPCRs. The secondary structure of the bent conformation with the ionic lock present is shown (Left) along with the CL3 region including the ends of TM5 and TM6 enlarged (Middle). The corresponding amino sequence of β36-m23 is shown for H6, with residues corresponding to CAMs in the β2 adrenergic receptor shown in yellow and the thermostabilizing mutation A282L shown in red. GPCRs with CAMs at the 6.34 site are shown on the right with reference to their evolutionary relationships. Amino acid residues corresponding to Leu289 (6.34) in the turkey β 1 AR are shown in parentheses.
receptor have shown different degrees of constitutive activity (33) . In the rat μ-opioid receptor, different substitutions of Thr 6.34 had different effects; the lysine mutant was constitutively active, whereas the aspartate mutant had lower basal activity and decreased ability to activate G proteins (34) . Several human diseases have also been caused by mutations in this region. Mutation of this site in the luteinizing hormone receptor gene causes male gonadotropin-independent precocious puberty (35) and the analogous mutation in the thyrotropin receptor causes hyperfunctioning thyroid adenomas (36) . Increased activity of these receptors could be due to the perturbing effect of the mutations on the structure and stabilization of the inactive state.
Methods
Purification and Crystallization. For the preparation of β 1 AR36-M23 with either cyanopindolol or iodocyanopindolol bound (crystals t148, t468, and t756), baculovirus-expressed receptor was solubilized in β-decylmaltoside and purified by Ni 2þ -affinity chromatography and alprenolol sepharose ligand affinity chromatography, with detergent exchange to octylthioglucoside (0.35%) on the ligand affinity column (28, 37) . Crystallization was by vapor diffusion with addition of receptor (5.5 mg∕mL) to an equal volume (0.5-1.0 μL) 0.1 M N-(2-acetamido)iminodiacetate-NaOH, pH 6.9-7.3, 29-33% PEG 600.
For crystallization of β 1 AR36-M23 with carazolol bound (crystal t1118), detergent was exchanged to Hega-10 (0.35%) and receptor was eluted with 50 μM carazolol. Prior to crystallization, ligand and detergent concentrations were increased to 0.5 mM and 0.5%, respectively. Crystallization was by vapor diffusion with addition of 200 nL receptor (9 mg∕mL) to an equal volume of precipitant solution (0.1 M Tris • HCl, pH 8.1, 40% PEG 400). Crystals were cryoprotected by a very short soak in either 60% PEG600 (t148), 40% PEG400 (t1118), or 35% PEG600 and 5% glycerol (t468). No additional cryoprotectant was added to crystal t756 (iodocyanopindolol).
Crystallography. Diffraction data for crystals t148 and t756 were collected at 100 K with a MarCCD detector on beamline ID23-2 at the European Synchrotron Radiation Facility (λ ¼ 0.873 Å). Data for crystals t468 and t1118 were collected at 100 K with a Pilatus detector on beamline X06SA at the Swiss Light Source (λ ¼ 0.98 and 1.00 Å, respectively). Each dataset was collected from multiple positions on a single crystal, following extensive screening. Diffraction data were processed with MOSFLM and SCALA (38) . Because the diffraction was anisotropic, different wedges of data were processed to different resolutions and consequently the completeness of the highest resolution shell is low for crystals t148, t468, and t1118 (Table S1 ). All structures were obtained with molecular replacement using PHASER (39) starting from the 2VT4 model (11) . Refinement was carried out in PHENIX (40) and REFMAC (41) with application of strict noncrystallographic symmetry averaging between appropriate regions of the two independent monomers in the asymmetric unit. Structure validation was performed using the MolProbity Web server.
